APA (7th ed.) Citation

Willett, C. G., Duda, D. G., di Tomaso, E., Boucher, Y., Ancukiewicz, M., Sahani, D. V., . . . Jain, R. K. (2009). Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study. Journal of clinical oncology, 27(18), 3020-3026. https://doi.org/10.1200/JCO.2008.21.1771

Chicago Style (17th ed.) Citation

Willett, Christopher G., et al. "Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study." Journal of Clinical Oncology 27, no. 18 (2009): 3020-3026. https://doi.org/10.1200/JCO.2008.21.1771.

MLA (9th ed.) Citation

Willett, Christopher G., et al. "Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study." Journal of Clinical Oncology, vol. 27, no. 18, 2009, pp. 3020-3026, https://doi.org/10.1200/JCO.2008.21.1771.